🔎 Trials Near Me

Početna › Migrena › North Carolina

Kliničke studije za Migrena u državi North Carolina

12 studija za Migrena traži sudionike na lokacijama u državi North Carolina.

Gradovi u državi North Carolina

Službeni tekst studije (engleski)

Study of EVO756 in Adults With Migraine

  • Asheville Neurology Specialists, Pa, Asheville
  • Eximia Research NC, Raleigh
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07616128

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

  • Accellacare - Piedmont, Statesville
  • Accellacare of Piedmont HealthCare, Statesville
  • Accellacare US Inc., Winston-Salem
U tijeku regrutacijaFaza 1
Od 6 do 11 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06995729

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • OnSite Clinical Solutions, LLC, Charlotte
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • OnSite Clinical Solutions, LLC, Charlotte
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04649242

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Onsite Clinical Solutions Park Cedar Dr., Charlotte
  • Onsite Clinical Solutions Mecklenburg, Charlotte
  • Onsite Clinical Solutions Ballantyne, Charlotte
  • i još 2
U tijeku regrutacijaFaza 4
Od 18 do 70 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834, Charlotte
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT05125302

A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine

  • Queen City Clinical Research, PLLC, Charlotte
U tijeku regrutacija
Od 22 do 84 godina · Oba spola · Ažurirano 28. kol 2026. · NCT07719608

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • OnSite Clinical Solutions, Charlotte
  • Guildford Neurologic Research Partners, LLC, Greensboro
  • Headache Wellness Center, Greensboro
  • i još 2
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07645924

BE WELL With Migraine: Brain Education and WELLness With Migraine

  • Wake Forest University Health Sciences, Winston-Salem
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT05987592

Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • Evidera, a PPD business unit, Wilmington
U tijeku regrutacijaOpažajna studija
Od 0 godina i više · Žene · Ažurirano 5. svi 2026. · NCT05046613

Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

  • Iqvia /Id# 266904, Durham
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Žene · Ažurirano 15. pro 2025. · NCT05158894

Aimovig Pregnancy Exposure Registry

  • IQVIA Virtual Site, Durham
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 99 godina · Žene · Ažurirano 4. stu 2025. · NCT06150781

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.